KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Debt Ratio (2017 - 2025)

Aquestive Therapeutics has reported Debt Ratio over the past 9 years, most recently at 0.23 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.23 for Q4 2025, down 27.08% from a year ago — trailing twelve months through Dec 2025 was 0.23 (down 27.08% YoY), and the annual figure for FY2025 was 0.23, down 27.08%.
  • Debt Ratio for Q4 2025 was 0.23 at Aquestive Therapeutics, up from 0.22 in the prior quarter.
  • Over the last five years, Debt Ratio for AQST hit a ceiling of 1.02 in Q3 2022 and a floor of 0.12 in Q1 2024.
  • Median Debt Ratio over the past 5 years was 0.6 (2021), compared with a mean of 0.56.
  • Biggest five-year swings in Debt Ratio: plummeted 81.98% in 2024 and later surged 165.07% in 2025.
  • Aquestive Therapeutics' Debt Ratio stood at 0.86 in 2021, then increased by 5.73% to 0.91 in 2022, then plummeted by 47.53% to 0.48 in 2023, then crashed by 33.11% to 0.32 in 2024, then decreased by 27.08% to 0.23 in 2025.
  • The last three reported values for Debt Ratio were 0.23 (Q4 2025), 0.22 (Q3 2025), and 0.37 (Q2 2025) per Business Quant data.